GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells.

MLA

Miller, Zoey A., et al. “GLUT1 Inhibitor BAY-876 Induces Apoptosis and Enhances Anti-Cancer Effects of Bitter Receptor Agonists in Head and Neck Squamous Carcinoma Cells.” Cell Death Discovery, vol. 10, no. 1, July 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41420-024-02106-z.

APA

Miller, Z. A., Muthuswami, S., Mueller, A., Ma, R. Z., Sywanycz, S. M., Naik, A., Huang, L., Brody, R. M., Diab, A., Carey, R. M., & Lee, R. J. (2024). GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells. Cell Death Discovery, 10(1), 1–13. https://doi.org/10.1038/s41420-024-02106-z

Chicago

Miller, Zoey A., Sahil Muthuswami, Arielle Mueller, Ray Z. Ma, Sarah M. Sywanycz, Anusha Naik, Lily Huang, et al. 2024. “GLUT1 Inhibitor BAY-876 Induces Apoptosis and Enhances Anti-Cancer Effects of Bitter Receptor Agonists in Head and Neck Squamous Carcinoma Cells.” Cell Death Discovery 10 (1): 1–13. doi:10.1038/s41420-024-02106-z.